Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT02579226
Title A Phase I Study of Safety, Tolerability, and PK of AZD2811 in Patients With Advanced Solid Tumors
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements No
Sponsors AstraZeneca
Indications

lung small cell carcinoma

Advanced Solid Tumor

Therapies

Irinotecan

AZD2811

Age Groups: adult
Covered Countries USA


No variant requirements are available.